Cargando…

Detecting drug-drug interactions using artificial neural networks and classic graph similarity measures

Drug-drug interactions are preventable causes of medical injuries and often result in doctor and emergency room visits. Computational techniques can be used to predict potential drug-drug interactions. We approach the drug-drug interaction prediction problem as a link prediction problem and present...

Descripción completa

Detalles Bibliográficos
Autores principales: Shtar, Guy, Rokach, Lior, Shapira, Bracha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675052/
https://www.ncbi.nlm.nih.gov/pubmed/31369568
http://dx.doi.org/10.1371/journal.pone.0219796
_version_ 1783440605635936256
author Shtar, Guy
Rokach, Lior
Shapira, Bracha
author_facet Shtar, Guy
Rokach, Lior
Shapira, Bracha
author_sort Shtar, Guy
collection PubMed
description Drug-drug interactions are preventable causes of medical injuries and often result in doctor and emergency room visits. Computational techniques can be used to predict potential drug-drug interactions. We approach the drug-drug interaction prediction problem as a link prediction problem and present two novel methods for drug-drug interaction prediction based on artificial neural networks and factor propagation over graph nodes: adjacency matrix factorization (AMF) and adjacency matrix factorization with propagation (AMFP). We conduct a retrospective analysis by training our models on a previous release of the DrugBank database with 1,141 drugs and 45,296 drug-drug interactions and evaluate the results on a later version of DrugBank with 1,440 drugs and 248,146 drug-drug interactions. Additionally, we perform a holdout analysis using DrugBank. We report an area under the receiver operating characteristic curve score of 0.807 and 0.990 for the retrospective and holdout analyses respectively. Finally, we create an ensemble-based classifier using AMF, AMFP, and existing link prediction methods and obtain an area under the receiver operating characteristic curve of 0.814 and 0.991 for the retrospective and the holdout analyses. We demonstrate that AMF and AMFP provide state of the art results compared to existing methods and that the ensemble-based classifier improves the performance by combining various predictors. Additionally, we compare our methods with multi-source data-based predictors using cross-validation. In the multi-source data comparison, our methods outperform various ensembles created using 29 different predictors based on several data sources. These results suggest that AMF, AMFP, and the proposed ensemble-based classifier can provide important information during drug development and regarding drug prescription given only partial or noisy data. Additionally, the results indicate that the interaction network (known DDIs) is the most useful data source for identifying potential DDIs and that our methods take advantage of it better than the other methods investigated. The methods we present can also be used to solve other link prediction problems. Drug embeddings (compressed representations) created when training our models using the interaction network have been made public.
format Online
Article
Text
id pubmed-6675052
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-66750522019-08-06 Detecting drug-drug interactions using artificial neural networks and classic graph similarity measures Shtar, Guy Rokach, Lior Shapira, Bracha PLoS One Research Article Drug-drug interactions are preventable causes of medical injuries and often result in doctor and emergency room visits. Computational techniques can be used to predict potential drug-drug interactions. We approach the drug-drug interaction prediction problem as a link prediction problem and present two novel methods for drug-drug interaction prediction based on artificial neural networks and factor propagation over graph nodes: adjacency matrix factorization (AMF) and adjacency matrix factorization with propagation (AMFP). We conduct a retrospective analysis by training our models on a previous release of the DrugBank database with 1,141 drugs and 45,296 drug-drug interactions and evaluate the results on a later version of DrugBank with 1,440 drugs and 248,146 drug-drug interactions. Additionally, we perform a holdout analysis using DrugBank. We report an area under the receiver operating characteristic curve score of 0.807 and 0.990 for the retrospective and holdout analyses respectively. Finally, we create an ensemble-based classifier using AMF, AMFP, and existing link prediction methods and obtain an area under the receiver operating characteristic curve of 0.814 and 0.991 for the retrospective and the holdout analyses. We demonstrate that AMF and AMFP provide state of the art results compared to existing methods and that the ensemble-based classifier improves the performance by combining various predictors. Additionally, we compare our methods with multi-source data-based predictors using cross-validation. In the multi-source data comparison, our methods outperform various ensembles created using 29 different predictors based on several data sources. These results suggest that AMF, AMFP, and the proposed ensemble-based classifier can provide important information during drug development and regarding drug prescription given only partial or noisy data. Additionally, the results indicate that the interaction network (known DDIs) is the most useful data source for identifying potential DDIs and that our methods take advantage of it better than the other methods investigated. The methods we present can also be used to solve other link prediction problems. Drug embeddings (compressed representations) created when training our models using the interaction network have been made public. Public Library of Science 2019-08-01 /pmc/articles/PMC6675052/ /pubmed/31369568 http://dx.doi.org/10.1371/journal.pone.0219796 Text en © 2019 Shtar et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Shtar, Guy
Rokach, Lior
Shapira, Bracha
Detecting drug-drug interactions using artificial neural networks and classic graph similarity measures
title Detecting drug-drug interactions using artificial neural networks and classic graph similarity measures
title_full Detecting drug-drug interactions using artificial neural networks and classic graph similarity measures
title_fullStr Detecting drug-drug interactions using artificial neural networks and classic graph similarity measures
title_full_unstemmed Detecting drug-drug interactions using artificial neural networks and classic graph similarity measures
title_short Detecting drug-drug interactions using artificial neural networks and classic graph similarity measures
title_sort detecting drug-drug interactions using artificial neural networks and classic graph similarity measures
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675052/
https://www.ncbi.nlm.nih.gov/pubmed/31369568
http://dx.doi.org/10.1371/journal.pone.0219796
work_keys_str_mv AT shtarguy detectingdrugdruginteractionsusingartificialneuralnetworksandclassicgraphsimilaritymeasures
AT rokachlior detectingdrugdruginteractionsusingartificialneuralnetworksandclassicgraphsimilaritymeasures
AT shapirabracha detectingdrugdruginteractionsusingartificialneuralnetworksandclassicgraphsimilaritymeasures